China has emerged as a big player in biotechnology, and major drugmakers and investors are catching on. WSJ reporter Peter Loftus tells us how China surged ahead in the biotech race, and why big pharma sees it as an opportunity. Plus, WSJ reporter Kate Clark introduces us to the whiz kids who dropped out of college to pursue their AI dreams—and are getting investors to pay their bills. Belle Lin hosts.
Sign up for the WSJ's free Technology newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.